Drug Addiction

FDA says no to anti-addiction rule on Ritalin, painkillers

FDA says no to anti-addiction rule on Ritalin, painkillers

By Fiona Barry

The US Food and Drug Administration has rejected a petition to force drugmakers to reformulate CNS-acting drugs like Adderall, Ritalin, and painkillers to prevent illegal use, but experts say the rule is only a matter of time.

FDA Shifts Focus to Abuse-Deterrent Generic Opioid Development

FDA Shifts Focus to Abuse-Deterrent Generic Opioid Development

By Zachary Brennan

The US Food and Drug Administration (FDA) can require opioid generics to have abuse-deterrent properties if the same requirements are applicable to their brand name counterparts, FDA Commissioner Margaret Hamburg said in a letter to Rep. Fred Upton (R-Mich.)...

Spotlight

Follow us

Webinars

Featured Suppliers

All